Redwood Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-534,560
| Closed | -$2.15M | – | 354 |
|
|
2024
Q3 | $2.15M | Buy |
534,560
+58,783
| +12% | +$236K | 0.19% | 100 |
|
|
2024
Q2 | $2.86M | Buy |
475,777
+109,086
| +30% | +$656K | 0.25% | 85 |
|
|
2024
Q1 | $3.19M | Buy |
366,691
+84,072
| +30% | +$732K | 0.3% | 79 |
|
|
2023
Q4 | $3.23M | Sell |
282,619
-47,188
| -14% | -$540K | 0.3% | 63 |
|
|
2023
Q3 | $3.18M | Sell |
329,807
-50,859
| -13% | -$490K | 0.28% | 88 |
|
|
2023
Q2 | $3.76M | Buy |
380,666
+47,572
| +14% | +$470K | 0.39% | 76 |
|
|
2023
Q1 | $3.5M | Buy |
333,094
+98,235
| +42% | +$1.03M | 0.38% | 79 |
|
|
2022
Q4 | $2.91M | Sell |
234,859
-10,387
| -4% | -$129K | 0.39% | 62 |
|
|
2022
Q3 | $2.54M | Buy |
245,246
+8,808
| +4% | +$91.3K | 0.53% | 33 |
|
|
2022
Q2 | $2.73M | Buy |
236,438
+12,186
| +5% | +$140K | 0.46% | 48 |
|
|
2022
Q1 | $2.82M | Buy |
224,252
+32,631
| +17% | +$410K | 0.42% | 67 |
|
|
2021
Q4 | $2.23M | Buy |
191,621
+34,546
| +22% | +$403K | 0.29% | 84 |
|
|
2021
Q3 | $2.05M | Buy |
157,075
+15,720
| +11% | +$205K | 0.29% | 73 |
|
|
2021
Q2 | $1.82M | Buy |
141,355
+9,190
| +7% | +$118K | 0.3% | 62 |
|
|
2021
Q1 | $1.48M | Buy |
132,165
+33,289
| +34% | +$372K | 0.28% | 65 |
|
|
2020
Q4 | $1.13M | Sell |
98,876
-26,564
| -21% | -$303K | 0.19% | 94 |
|
|
2020
Q3 | $1.13M | Buy |
125,440
+26,849
| +27% | +$241K | 0.28% | 74 |
|
|
2020
Q2 | $1.02M | Buy |
98,591
+18,654
| +23% | +$192K | 0.29% | 38 |
|
|
2020
Q1 | $807K | Sell |
79,937
-9,933
| -11% | -$100K | 0.51% | 40 |
|
|
2019
Q4 | $1.2M | Sell |
89,870
-33,292
| -27% | -$443K | 0.3% | 82 |
|
|
2019
Q3 | $1.06M | Buy |
123,162
+27,749
| +29% | +$238K | 0.29% | 77 |
|
|
2019
Q2 | $1.04M | Buy |
+95,413
| New | +$1.04M | 0.29% | 53 |
|